Yayın: The efficacy and safety of ct-p13 as first-line and subsequent-line therapy in patients with ankylosing spondylitis: Real-life data from Turkbio cohort
| dc.contributor.author | Uslu, Sadettin | |
| dc.contributor.author | Gülle, Semih | |
| dc.contributor.author | Can, Gerçek | |
| dc.contributor.author | Şenel, Soner | |
| dc.contributor.author | Çapar, Sedat | |
| dc.contributor.author | Akar, Servet | |
| dc.contributor.author | Koca, Süleyman Serdar | |
| dc.contributor.author | Tufan, Abdurrahman | |
| dc.contributor.author | Yazıcı, Ayten | |
| dc.contributor.author | Yılmaz, Sema | |
| dc.contributor.author | Inanç, Nevşün | |
| dc.contributor.author | Birlik, Merih | |
| dc.contributor.author | Solmaz, Dilek | |
| dc.contributor.author | Cefle, Ayşe | |
| dc.contributor.author | Göker, Berna | |
| dc.contributor.author | Yolbaş, Servet | |
| dc.contributor.author | Krough, Niels Steen | |
| dc.contributor.author | Yılmaz, Neslihan | |
| dc.contributor.author | Erten, Şükran | |
| dc.contributor.author | Beş, Cemal | |
| dc.contributor.author | Soysal, Özgül | |
| dc.contributor.author | Öztürk, Mehmet Akif | |
| dc.contributor.author | Haznedaroğlu, Seminur | |
| dc.contributor.author | Yavuz, Şule | |
| dc.contributor.author | Direşkeneli, Haner | |
| dc.contributor.author | Önen, Fatoş | |
| dc.contributor.author | Sarı, İsmail | |
| dc.contributor.buuauthor | Dalkılıç, Hüseyin Ediz | |
| dc.contributor.buuauthor | DALKILIÇ, HÜSEYİN EDİZ | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | İç Hastalıkları Ana Bilim Dalı | |
| dc.contributor.researcherid | ERI-0246-2022 | |
| dc.date.accessioned | 2024-12-02T05:48:28Z | |
| dc.date.available | 2024-12-02T05:48:28Z | |
| dc.date.issued | 2022-09-01 | |
| dc.description | Bu çalışma, 10-14 Kasım 2022tarihleri arasında Philadelphia[Amerika Birleşik Devletleri ]’da düzenlenen Annual Meeting of the American-College-of-Rheumatology (ACR)’da bildiri olarak sunulmuştur. | |
| dc.description.sponsorship | Amer Coll Rheumatol | |
| dc.identifier.endpage | 849 | |
| dc.identifier.issn | 2326-5191 | |
| dc.identifier.issue | Supplement 9, Special Issue SI | |
| dc.identifier.startpage | 847 | |
| dc.identifier.uri | https://hdl.handle.net/11452/48739 | |
| dc.identifier.volume | 74 | |
| dc.identifier.wos | 000877386500424 | |
| dc.indexed.wos | WOS.SCI | |
| dc.indexed.wos | WOS.ISTP | |
| dc.language.iso | en | |
| dc.publisher | Wiley | |
| dc.relation.journal | Arthritis & Rheumatology | |
| dc.relation.publicationcategory | Konferans Öğesi – Uluslararası | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Science & technology | |
| dc.subject | Life sciences & biomedicine | |
| dc.subject | Rheumatology | |
| dc.title | The efficacy and safety of ct-p13 as first-line and subsequent-line therapy in patients with ankylosing spondylitis: Real-life data from Turkbio cohort | |
| dc.type | Other | |
| dc.type.subtype | Meeting Abstract | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/İç Hastalıkları Ana Bilim Dalı | |
| local.indexed.at | WOS | |
| relation.isAuthorOfPublication | 1613225c-2f43-4052-9f82-210c854edcf4 | |
| relation.isAuthorOfPublication.latestForDiscovery | 1613225c-2f43-4052-9f82-210c854edcf4 |
